Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Pharmaceutical Research
|
June 8, 2007
Characterization of tableting using the OSDRC system
Kazuyuki Shimizu, Masaki Ando, Yukiharu Nakayama
Clinical Pharmacokinetics
|
June 10, 2003
Pharmacokinetic and pharmacodynamic studies of SK-896, a new human motilin analogue, in healthy male volunteers
Yoshiyuki Furuta, Yukiharu Nakayama, Mitsuyoshi Nakashima, et al.
Journal of Diabetes and Its Complications
|
October 30, 2003
Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats
Noriaki Kato, Satomi Yashima, Takeshi Suzuki, et al.
International Journal of Pharmaceutics
|
January 16, 2007
Development and evaluation of a novel dry-coated tablet technology for pellets as a substitute for the conventional encapsulation technology
Masaki Ando, Sayaka Kojima, Yuichi Ozeki, et al.
International Journal of Pharmaceutics
|
January 30, 2007
Evaluation of a novel sugar coating method for moisture protective tablets
Masaki Ando, Rina Ito, Yuichi Ozeki, et al.
Biological & Pharmaceutical Bulletin
|
August 21, 2002
Effects of SK-896, a new human motilin analogue ([Leu13]motilin-Hse), on postoperative ileus in dogs after laparotomy
Yoshiyuki Furuta, Motohiro Takeda, Yukiharu Nakayama, et al.
Journal of Neurochemistry
|
December 9, 2004
Neurotrophin-3-induced production of nerve growth factor is suppressed in Schwann cells exposed to high glucose: involvement of the polyol pathway
Takeshi Suzuki, Hiromi Sekido, Noriaki Kato, et al.
Drug Metabolism and Pharmacokinetics
|
February 1, 2005
Functional characterization of single nucleotide polymorphisms with amino acid substitution in CYP1A2, CYP2A6, and CYP2B6 found in the Japanese population
Masahiko Iwasaki, Yoshinobu Yoshimura, Satoru Asahi, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Pharmaceutical Research
|
June 8, 2007
Characterization of tableting using the OSDRC system
Kazuyuki Shimizu, Masaki Ando, Yukiharu Nakayama
Clinical Pharmacokinetics
|
June 10, 2003
Pharmacokinetic and pharmacodynamic studies of SK-896, a new human motilin analogue, in healthy male volunteers
Yoshiyuki Furuta, Yukiharu Nakayama, Mitsuyoshi Nakashima, et al.
Journal of Diabetes and Its Complications
|
October 30, 2003
Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats
Noriaki Kato, Satomi Yashima, Takeshi Suzuki, et al.
International Journal of Pharmaceutics
|
January 16, 2007
Development and evaluation of a novel dry-coated tablet technology for pellets as a substitute for the conventional encapsulation technology
Masaki Ando, Sayaka Kojima, Yuichi Ozeki, et al.
International Journal of Pharmaceutics
|
January 30, 2007
Evaluation of a novel sugar coating method for moisture protective tablets
Masaki Ando, Rina Ito, Yuichi Ozeki, et al.
Biological & Pharmaceutical Bulletin
|
August 21, 2002
Effects of SK-896, a new human motilin analogue ([Leu13]motilin-Hse), on postoperative ileus in dogs after laparotomy
Yoshiyuki Furuta, Motohiro Takeda, Yukiharu Nakayama, et al.
Journal of Neurochemistry
|
December 9, 2004
Neurotrophin-3-induced production of nerve growth factor is suppressed in Schwann cells exposed to high glucose: involvement of the polyol pathway
Takeshi Suzuki, Hiromi Sekido, Noriaki Kato, et al.
Drug Metabolism and Pharmacokinetics
|
February 1, 2005
Functional characterization of single nucleotide polymorphisms with amino acid substitution in CYP1A2, CYP2A6, and CYP2B6 found in the Japanese population
Masahiko Iwasaki, Yoshinobu Yoshimura, Satoru Asahi, et al.
Page
of 1